- CLINICAL BRIEFINGS
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history.
You Might Also Like
First independent survey of deaths in Gaza reports more than 80,000 fatalities
It has been difficult to gather reliable estimates of deaths during the war in Gaza.Credit: Abdalhkem Abu Riash/Anadolu via GettyAlmost...
‘I didn’t know someone could pursue astronomy as a career’
Willice Obonyo (seated) shows his students at the Technical University of Kenya how to use a tabletop radio telescope to...
Will Gates and other funders save massive public health database at risk from Trump cuts?
The United Nations, governments and aid agencies are scrambling to save one of the world’s largest public-health databases from extinction....
study of 100,000 applicants hints at why
The Matthew effect describes how scientists who win grant funding early in their careers are more likely to have success...